Avalo Therapeutics (AVTX) Gross Margin Growth (1y) (2018 - 2024)
Avalo Therapeutics (AVTX) Gross Margin Growth (1y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 372.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -18,209.00 |
| Dec 31, 2023 | 10,790.00 |
| Sep 30, 2023 | -10,113.00 |
| Jun 30, 2023 | 4,159.00 |
| Mar 31, 2023 | -5,462.00 |
| Dec 31, 2022 | 12,441.00 |
| Sep 30, 2022 | 6,373.00 |
| Jun 30, 2022 | -14,922.00 |
| Mar 31, 2022 | -4,510.00 |
| Dec 31, 2021 | -18,833.00 |
| Sep 30, 2021 | -6,033.00 |
| Jun 30, 2021 | 336.00 |
| Mar 31, 2021 | -1,388.00 |
| Dec 31, 2020 | 2,092.00 |
| Sep 30, 2020 | -92.00 |
| Jun 30, 2020 | 10,108.00 |
| Mar 31, 2020 | 2,681.00 |
| Dec 31, 2019 | 765.00 |
| Sep 30, 2019 | 7,034.00 |
| Jun 30, 2019 | -7,717.00 |